Term 2 Pharm - Anxiety & Depression Drugs Flashcards
Depression
- 14.3 % Medical students
- US $100 billion/yr
- ## “In all regions, neuropsychiatric conditions are the most important causes of disability, accounting for around one third of YLD among adults (years lost to disability).”
Libby Zion
- Fever (107F), agitation, shaking
- Meperidine and restraints
Main target of antidepressants?
- All the antidepressant drugs now in use modulate monoamine neurotransmission.
- Problem with Monoamines= Delay (6-8 weeks to exert their effects)
- Efficacious in 60–70% of patients.
What are amines?
In amines, the hydrogen atoms in the ammonia have been replaced one at a time by hydrocarbon groups
What are the key actors in the monoamine hypothesis of depression?
Serotonin, Norepinephrine, Dopamine
(Monoamine-deficiencyhypothesis)
Current Leading Theory: Enhanced Neuroplasticity(Structural and Functional)
Since 1955 – nothing really new or novel has emerged – 27 drugs have come to market - all work by increasing monoamines at the synapse, through a variety of different mechanisms.
First Generation: TCA and MAO-I (1955 – 1986)
Second Generation: SSRI, SNRI, other (1986 – now)
NO improvement in efficacy of drugs, just an improvement in their tolerability Old does not mean less than or worse
Old to New
Class Leaders (model drugs of each category) of Antidepressants
Serotonin
- SSRI (citalopram)
Norepinephrine
- SNRI (venlafaxine)
- TCA (nortryptiline)
Dopamine
- NDRI (bupropion)
What do SSRI’s do?
SSRI’s – selective serotonin reuptake inhibitors
The basic mechanism is that the drug, blocks the serotonin reuptake molecule (by acting as a serotonin analogue) – thus keeping more of the serotonin monoamine in the synapse.
have numerous other properties that lead to side effects. HUGE potential for cross reactivity of other unintended receptors – potentially leading to multiple side effects
Where are most of the cells that use serotonin as a primary signaling messenger?
In the Raphe Nucleus in the brain stem and mid-brain – with projections throughout the brain.
SSRI
Citalopram (Celexa)
(blocks the serotonin reuptake molecule)
Side Effects: GI, sexual problems, sleep, sweating, low Na+, mania.
Black Box: Increase SI (Suicidal Intentions) up to 25yo –> this applies to all drugs of this class*
Interactions: weak 2D6 inhibition
Can increase MAO-I’s and TCA levels
Other: QTc prolongation average 18msec at 60mg/day (dose related increase)
(>480msec – risk of Torsade’s)
What are the SSRI’s
SSRI’s:
- citalopram
- escitalopram
- fluoxetine
- paroxetine
- sertraline
- fluvoxamine
Norepinephrine (SNRI)
SNRI’s:
Most NE drugs have what is called “dual action” Meaning they increase both serotonin and norepinephrine in the synapse.
SNRI
Venlafaxine/ ER (Effexor/XR)
Side effects: GI, sexual, sleep, sweating, Na+, mania
Diastolic blood pressure increase*
Black Box: SI up to 25yo
Interactions: very weak 2D6 -, slight increase of
MAO-I & TCA’s
Other: dual re-uptake >225mg/day
discontinuation sx’s can be bad… BAD withdrawal side effects (SNRI) with FAST onset
In part because of half life (short) as opposed to other classes
TCA or tricyclic drugs
2nd group of drugs that modulate Norepinephrine
most (not all) … e.g.: of the TCA’s have “dual action”
TCA Drugs:
- nortryptiline
- imipramine
- Amitriptyline
- desipramine
TCA’s are either
- Tertiary Amines – having all three hydrogen replaced by other subgroups
- Secondary Amines – where one of the 3 side groups is cleaved off and H again in its place
(Secondary Amines are metabolites of Tertiary Amines
This (cleaving to secondary amine) does 2 things
- reduces side effects - shifts the predominant action more toward Norepinephrine reuptake inhibition.
(See slide 21 for specifics)
TCA
Nortriptyline (Pamelor)
(A secondary amine)
Dose: 75 – 150mg/day
Level:50 – 150 ng/ml
(Inverted U shape efficacy curve (levels between 50 – 150 are ideal anything below or above are less efficacious)
Side effects: wt gain, sedation, ACh, hypotension, arrhythmia, sexual, sweating
Interactions: 2D6 inhibition
MAO-I, TCA’s, tramadol
Other: Lethal in overdose (LD50
is 2000-3000mg)
*it has an easy to follow blood level and well established serum level correlated to clinical effect.